Tobam Amarin Corp Plcuk Transaction History

Tobam

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$4.04 - $5.31 $143,824 - $189,036	-35,600 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$3.64 - $7.76 $69,888 - $148,992	19,200 Added 117.07%	35,600 $150,000
Q2 2020 Aug 17, 2020	BUY	$4.78 - $8.26 $53,536 - $92,512	11,200 Added 215.38%	16,400 $113,000
Q1 2020 May 07, 2020	BUY	$4.0 - $21.53 $9,600 - $51,672	2,400 Added 85.71%	5,200 $21,000
Q4 2019 Feb 10, 2020	SELL	$13.94 - $24.12 $6,970 - $12,060	-500 Reduced 15.15%	2,800 $60,000
Q3 2019 Nov 12, 2019	BUY	$13.89 - $23.16 $1,389 - $2,316	100 Added 3.13%	3,300 $50,000
Q2 2019 Aug 13, 2019	BUY	$16.27 - $20.51 $16,270 - $20,510	1,000 Added 45.45%	3,200 $62,000
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $5,044 - $8,932	400 Added 22.22%	2,200 $46,000
Q4 2018 Feb 11, 2019	BUY	$12.41 - $22.98 $22,338 - $41,364	1,800 New	1,800 $24,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

Stay updated on Tobam with notifications on news.